Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Dopamine Receptor
    (1)
  • Neurotensin Receptor
    (1)
  • Potassium Channel
    (1)
  • Others
    (3)
Filter
Search Result
Results for "

psychotic disorders

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    6
    TargetMol | Inhibitors_Agonists
  • Recombinant Protein
    1
    TargetMol | Recombinant_Protein
Acetophenazine dimaleate
T102325714-00-1
Acetophenazine dimaleate is an antipsychotic agent, effective in anxious depression. Acetophenazine dimaleate primarily targets the dopamine D2 receptor.
  • $32
In Stock
Size
QTY
SR 142948
T23386184162-64-9
SR 142948 is a neurotensin (NT) receptor antagonist.
  • $1,330
8-10 weeks
Size
QTY
Potassium Channel Activator 1
ZINC34634569
T10674908608-06-0
Potassium Channel Activator 1 can be used in studies about the treatment of disorders or conditions wherein the dopaminergic system is disrupted such as mood disorders ADHD, schizophrenia, and other psychotic states.
  • $90
In Stock
Size
QTY
Perazine dimalonate
Taxilan, Psytomin, Pernazine, 84-97-9
T20236214777-25-4
Perazine dimlonate, a compound belonging to the phenothiazine class, exhibits neuroleptic properties. It is primarily used to treat psychotic disorders.
  • Inquiry Price
10-14 weeks
Size
QTY
E-5842 (Citrate)
E-5842 Citrate, E5842 Citrate, E 5842 Citrate
T27232220120-14-9
E-5842 (Citrate), an opioid receptor agonist, is used potentially for the treatment of psychotic disorders.
  • $1,520
6-8 weeks
Size
QTY
Endoxifen mesylate
T715781032008-71-1
Endoxifen, also known as N-desmethyl-4-hydroxytamoxifen, is a chemical that is under development for estrogen receptor-positive breast cancer. It is also being evaluated as an antipsychotic for treatment of mania and other psychotic disorders. Endoxifen is a nonsteroidal selective estrogen receptor modulator (SERM) of the triphenylethylene group. It is an active metabolite of tamoxifen and has been found to be effective in patients that have failed previous hormonal therapies (tamoxifen, aromatase inhibitors, and fulvestrant). The prodrug tamoxifen is metabolized by the CYP2D6 enzyme to produce afimoxifene (4-hydroxytamoxifen) and endoxifen.
  • $1,520
6-8 weeks
Size
QTY